I begge undersøgelser var det primære parameter for virkning antallet af patienter, der dannede blodpropper i blodårerne, eller som døde uanset årsag i løbet af behandlingsperioden.
In both studies, the main measure of effectiveness was the number of patients who formed blood clots in the veins or who died of any cause during the treatment period.